Featured Research

from universities, journals, and other organizations

New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease

Date:
May 5, 1999
Source:
University Of California, San Francisco
Summary:
Medical researchers have found that adding a simple molecular chain to a standard medication for lung disease creates a new therapy that shows promise for difficult-to-treat cases resulting from acute lung injury. Scientists from the University of California San Francisco led the team, which also included researchers from the University of Rochester and the Karolinska Institute in Sweden.

Medical researchers have found that adding a simple molecular chain to a standard medication for lung disease creates a new therapy that shows promise for difficult-to-treat cases resulting from acute lung injury. Scientists from the University of California San Francisco led the team, which also included researchers from the University of Rochester and the Karolinska Institute in Sweden.

The standard medication is artificial surfactant, a detergent-like liquid that is administered directly into the lungs. Studies in animal models showed the extra molecular chain--made of a compound bio-compatible with mammalian tissue--appears to act as a protective barrier, allowing normal function of a key substance that lines the air spaces in the lungs. This substance is natural surfactant, a lung secretion that is vital to normal pulmonary function because it keeps the lungs from collapsing after each breath.

Reporting today (May 4) at the annual meeting of the Pediatric Academic Societies in San Francisco, principal investigator H. William Taeusch, MD, of UCSF, said rats with diseased lungs treated with the enhanced medication had improved oxygen levels in the blood, an indication that lung function is not compromised.

"The study findings are dramatic, and we are excited at the potential of someday successfully treating infants and adults who have lung problems that don't respond well to current treatment. We have been frustrated with the poor outcome in these groups, and our results suggest that we could be on the road to a much-improved therapy," said Taeusch, who is a UCSF professor of pediatrics and chief of the Department of Pediatrics at the UCSF-affiliated San Francisco General Hospital Medical Center.

Some 5,000-10,000 infants and 100,000 adults in the U.S. suffer from acute lung injury every year. Their disease differs from premature babies who at birth suffer from respiratory distress syndrome--also known as hyaline membrane disease--and who respond very well to artificial surfactant therapy. In these premature babies, the immature lungs do not produce natural surfactant.

Artificial surfactant serves as a substitute for the missing substance until the babies' lungs mature and they begin to produce surfactant normally. The treatment is credited with saving the lives of thousands of newborns worldwide over the past two decades.

But in other patients, respiratory distress may be caused by damage to lung tissue. "In fact, the damaged tissue results in 'inactivation' of surfactant, so the very substance that is needed to help breathing is being disrupted," Tauesch said.

In newborns, lung tissue damage sometimes occurs during the birth process when meconium--fetal stool--in the amniotic fluid is inadvertently inhaled. In adults, tissue damage is associated with near-drowning, major trauma, pulmonary infection, complications related to cardiac surgery, and accidental aspiration of stomach contents.

In these forms of acute lung injury, blood or meconium interferes with normal surfactant function, making breathing and oxygenation of the blood more difficult. For example, if capillary walls inside the lungs are injured, they begin to leak blood and inflammatory debris which then fill up valuable air spaces and also inactivate the surfactant, Taeusch explained.

"Artificial surfactant is one of the treatments we have for these kinds of disorders, but the results have been very uneven. The goal in our research was to develop an 'inactivation proof' artificial surfactant," said Taeusch.

In studies with rats, the researchers compared the effectiveness of Survanta, an artificial surfactant product, and Survanta enhanced with a molecular chain, or polymer. The polymer mimics some of the effects of the natural proteins of surfactant. Not all of these proteins are incorporated in artificial surfactant because of the scientific difficulty of creating the synthetic versions.

"In our studies we overcame the absence of protein by adding the polymer," Taeusch said.

The new research on artificial surfactant is an extension of breakthrough work by UCSF scientist John Clements, MD, who was first to isolate and characterize natural lung surfactant in the 1950s. Twenty years later, he developed the first artificial surfactant. Clements is the Julius H. Comroe, Jr., professor of pulmonary biology at UCSF and served as co-investigator on the current study.

Taeusch said he plans to continue to study the mechanism of polymers in treating a variety of lung diseases. The UCSF team has applied for a patent on the polymer enhancement technique.

In addition to Taeusch and Clements, the research co-investigators are Karen W. Lu, MD, and Jon Goerke, MD, of UCSF; Pankaj Sarin, MD, of the University of Rochester; and Bengt Robertson, MD, of the Karolinksa Institute. The research was supported by grants from the UCSF Department of Pediatrics and the UCSF Committee on Research.


Story Source:

The above story is based on materials provided by University Of California, San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Francisco. "New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease." ScienceDaily. ScienceDaily, 5 May 1999. <www.sciencedaily.com/releases/1999/05/990505070200.htm>.
University Of California, San Francisco. (1999, May 5). New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/1999/05/990505070200.htm
University Of California, San Francisco. "New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease." ScienceDaily. www.sciencedaily.com/releases/1999/05/990505070200.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins